154 related articles for article (PubMed ID: 9298713)
1. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients.
Morré DJ; Reust T
J Bioenerg Biomembr; 1997 Jun; 29(3):281-9. PubMed ID: 9298713
[TBL] [Abstract][Full Text] [Related]
2. Response of a cell-surface NADH oxidase to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenylurea) (LY181984) modulated by redox.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1998 Mar; 1369(2):185-92. PubMed ID: 9518604
[TBL] [Abstract][Full Text] [Related]
3. The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1995 Nov; 1240(1):11-7. PubMed ID: 7495842
[TBL] [Abstract][Full Text] [Related]
4. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) at an external site.
Morré DJ
Biochim Biophys Acta; 1995 Dec; 1240(2):201-8. PubMed ID: 8541291
[TBL] [Abstract][Full Text] [Related]
5. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media.
Morré DJ; Wilkinson FE; Kim C; Cho N; Lawrence J; Morré DM; McClure D
Biochim Biophys Acta; 1996 Apr; 1280(2):197-206. PubMed ID: 8639694
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.
Morré DJ; Wu LY; Morré DM
Biochim Biophys Acta; 1997 Feb; 1355(2):114-20. PubMed ID: 9042331
[TBL] [Abstract][Full Text] [Related]
7. Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients.
Kim C; MacKellar WC; Cho NM; Byrn SR; Morré DJ
Biochim Biophys Acta; 1997 Mar; 1324(2):171-81. PubMed ID: 9092704
[TBL] [Abstract][Full Text] [Related]
8. A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984).
Morré DJ; Jacobs E; Sweeting M; de Cabo R; Morré DM
Biochim Biophys Acta; 1997 Apr; 1325(1):117-25. PubMed ID: 9106489
[TBL] [Abstract][Full Text] [Related]
9. Is the drug-responsive NADH oxidase of the cancer cell plasma membrane a molecular target for adriamycin?
Morré DJ; Kim C; Paulik M; Morré DM; Faulk WP
J Bioenerg Biomembr; 1997 Jun; 29(3):269-80. PubMed ID: 9298712
[TBL] [Abstract][Full Text] [Related]
10. A drug-responsive and protease-resistant peripheral NADH oxidase complex from the surface of HeLa S cells.
del Castillo-Olivares A; Yantiri F; Chueh PJ; Wang S; Sweeting M; Sedlak D; Morré DM; Burgess J; Morré DJ
Arch Biochem Biophys; 1998 Oct; 358(1):125-40. PubMed ID: 9750173
[TBL] [Abstract][Full Text] [Related]
11. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity.
Kishi T; Morré DM; Morré DJ
Biochim Biophys Acta; 1999 May; 1412(1):66-77. PubMed ID: 10354495
[TBL] [Abstract][Full Text] [Related]
12. Proton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N'-(4-cholorophenyl) urea (LY181984).
Sun E; Lawrence J; Morré DM; Sun I; Crane FL; MacKellar WC; Morré DJ
Biochem Pharmacol; 1995 Oct; 50(9):1461-8. PubMed ID: 7503797
[TBL] [Abstract][Full Text] [Related]
13. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients.
Morré DJ; Caldwell S; Mayorga A; Wu LY; Morré DM
Arch Biochem Biophys; 1997 Jun; 342(2):224-30. PubMed ID: 9186482
[TBL] [Abstract][Full Text] [Related]
14. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity.
Morré DJ; Chueh PJ; Lawler J; Morré DM
J Bioenerg Biomembr; 1998 Oct; 30(5):477-87. PubMed ID: 9932650
[TBL] [Abstract][Full Text] [Related]
15. A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients.
Chueh PJ; Morré DJ; Wilkinson FE; Gibson J; Morré DM
Arch Biochem Biophys; 1997 Jun; 342(1):38-47. PubMed ID: 9185612
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients.
Cho N; Chueh PJ; Kim C; Caldwell S; Morré DM; Morré DJ
Cancer Immunol Immunother; 2002 May; 51(3):121-9. PubMed ID: 11941450
[TBL] [Abstract][Full Text] [Related]
17. Isolation and identification of a protein with capsaicin-inhibited NADH oxidase activity from culture media conditioned by growth of HeLa cells.
Wilkinson F; Kim C; Cho N; Chueh PJ; Leslie S; Moya-Camarena S; Wu LY; Morré DM; Morré DJ
Arch Biochem Biophys; 1996 Dec; 336(2):275-82. PubMed ID: 8954575
[TBL] [Abstract][Full Text] [Related]
18. New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells.
Alonso MM; Encío I; Martínez-Merino V; Gil M; Migliaccio M
Br J Cancer; 2001 Nov; 85(9):1400-2. PubMed ID: 11720481
[TBL] [Abstract][Full Text] [Related]
19. NADH oxidase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms.
Wang S; Pogue R; Morré DM; Morré DJ
Biochim Biophys Acta; 2001 Jun; 1539(3):192-204. PubMed ID: 11420117
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a tumor-associated NADH oxidase (tNOX) from the HeLa cell surface.
Yantiri F; Morré DJ
Arch Biochem Biophys; 2001 Jul; 391(2):149-59. PubMed ID: 11437345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
